Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 1
1983 1
1989 1
1992 1
1993 14
1994 2
1995 6
1996 6
1997 8
1998 3
1999 5
2000 31
2001 47
2002 64
2003 115
2004 108
2005 124
2006 142
2007 199
2008 215
2009 213
2010 207
2011 234
2012 262
2013 282
2014 269
2015 310
2016 342
2017 369
2018 380
2019 395
2020 441
2021 503
2022 477
2023 456
2024 469
2025 546
2026 72

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,464 results

Results by year

Filters applied: . Clear all
Page 1
Levetiracetam.
Howard P, Remi J, Remi C, Charlesworth S, Whalley H, Bhatia R, Hitchens M, Mihalyo M, Wilcock A. Howard P, et al. J Pain Symptom Manage. 2018 Oct;56(4):645-649. doi: 10.1016/j.jpainsymman.2018.07.012. Epub 2018 Jul 21. J Pain Symptom Manage. 2018. PMID: 30036676 Free article. Review.
Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis.
Fang T, Valdes E, Frontera JA. Fang T, et al. Neurocrit Care. 2022 Feb;36(1):248-258. doi: 10.1007/s12028-021-01296-z. Epub 2021 Jul 20. Neurocrit Care. 2022. PMID: 34286461
The coprimary meta-analyses examined first seizure events in (1) levetiracetam versus no antiseizure medication and (2) levetiracetam versus other antiseizure medications in all ICH, TBI, SAH, and supratentorial neurosurgery populations. ...Levetiracetam may …
The coprimary meta-analyses examined first seizure events in (1) levetiracetam versus no antiseizure medication and (2) levetirace
Levetiracetam.
Alrabiah H. Alrabiah H. Profiles Drug Subst Excip Relat Methodol. 2019;44:167-204. doi: 10.1016/bs.podrm.2019.02.003. Epub 2019 Mar 25. Profiles Drug Subst Excip Relat Methodol. 2019. PMID: 31029217
A comprehensive profile of levetiracetam is presented in this chapter which includes its description, formula, elemental analysis, appearance, uses and applications. ...
A comprehensive profile of levetiracetam is presented in this chapter which includes its description, formula, elemental analysis, ap …
Levetiracetam.
Nash EM, Sangha KS. Nash EM, et al. Am J Health Syst Pharm. 2001 Jul 1;58(13):1195-9. doi: 10.1093/ajhp/58.13.1195. Am J Health Syst Pharm. 2001. PMID: 11449876 Review.
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of levetiracetam are reviewed. Levetiracetam is an adjunctive treatment for partial-onset epileptic seizures. ...Three clinical studies have demonstrated levetir
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of levetiracetam are reviewed. …
Levetiracetam-associated pancytopenia.
Unkun R, Kizilkilic EK, Delil S, Kemerdere R, Ozkara C. Unkun R, et al. Acta Neurol Belg. 2023 Aug;123(4):1625-1626. doi: 10.1007/s13760-022-02138-1. Epub 2022 Nov 7. Acta Neurol Belg. 2023. PMID: 36344882 No abstract available.
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.
Kaplan YC, Demir O. Kaplan YC, et al. Curr Neuropharmacol. 2021;19(11):1805-1824. doi: 10.2174/1570159X19666210211150856. Curr Neuropharmacol. 2021. PMID: 33573557 Free PMC article. Review.
This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin, carbamazepine, phenobarbital, and valproate) and two newer (lamotrigine and levetiracetam) AEDs during pregnancy. The review focuses on major and organ-specific m …
This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin, carbamazepine, phenobarbital, …
Subcutaneous levetiracetam for the management of seizures at the end of life.
Sutherland AE, Curtin J, Bradley V, Bush O, Presswood M, Hedges V, Naessens K. Sutherland AE, et al. BMJ Support Palliat Care. 2018 Jun;8(2):129-135. doi: 10.1136/bmjspcare-2016-001261. Epub 2017 Jul 22. BMJ Support Palliat Care. 2018. PMID: 28735270 Review.
RESULTS: 7 papers were identified from the literature review-four case reports and three observational case series-reporting on a total of 53 cases where subcutaneous levetiracetam was administered.We report 20 further cases of subcutaneous levetiracetam administrat …
RESULTS: 7 papers were identified from the literature review-four case reports and three observational case series-reporting on a total of 5 …
Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis.
Abdelgadir I, Hamud A, Kadri A, Akram S, Pullattayil A, Akobeng AK, Powell C. Abdelgadir I, et al. Arch Dis Child. 2021 Apr 21;106(5):470-476. doi: 10.1136/archdischild-2020-319573. Arch Dis Child. 2021. PMID: 33060105
There was no significant difference in cessation of seizure activities when levetiracetam was compared with phenytoin (risk ratio (RR)=1.03, 95% CI 0.98 to 1.09), levetiracetam to fosphenytoin (RR=1.16, 95% CI 1.00 to 1.35) or levetiracetam to valproate (RR=1 …
There was no significant difference in cessation of seizure activities when levetiracetam was compared with phenytoin (risk ratio (RR …
Levetiracetam in pediatrics.
Vigevano F. Vigevano F. J Child Neurol. 2005 Feb;20(2):87-93. doi: 10.1177/08830738050200020101. J Child Neurol. 2005. PMID: 15794171 Review.
Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. ...This review, based on the international literature, aims to identify and make known the possible indications for levetiracetam in childhood. Most studies s
Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. ...This review, based on
Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
Tan J, Paquette V, Levine M, Ensom MHH. Tan J, et al. Clin Pharmacokinet. 2017 Nov;56(11):1267-1285. doi: 10.1007/s40262-017-0537-1. Clin Pharmacokinet. 2017. PMID: 28353057 Review.
Levetiracetam is a broad-spectrum antiepileptic drug (AED) with a unique mechanism of action. ...Thus, clinical decision making is unlikely to be affected as a result of routine levetiracetam CPM. In general, routine CPM of levetiracetam cannot be recommended
Levetiracetam is a broad-spectrum antiepileptic drug (AED) with a unique mechanism of action. ...Thus, clinical decision making is un
6,464 results